Resumption of anticoagulation after major bleeding decreases the risk of stroke in patients with atrial fibrillation

This study aimed to (1) evaluate anticoagulation use after a major bleeding event on dabigatran or warfarin and (2) compare outcomes between patients discontinuing anticoagulation and those restarting dabigatran or warfarin. Methods This was...

http://ebm.bmj.com/cgi/content/short/22/3/107?rss=1

Source: Evidence-Based Medicine - June 9, 2017 Category: Internal Medicine Authors: Smit, M. D., Van Gelder, I. C. Tags: Therapeutics/Prevention Source Type: research